Farnesoid X receptor modulator 12β-(m-methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways

References

• Chai J, Du X, Chen S, Feng X, Cheng Y, Zhang L, Gao Y, et al. 2015. Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats. Int J Clin Exp Med. 8(2):1691–1702.
   PubMed Web of Science ®Google Scholar
• Chen P, Li J, Fan X, Zeng H, Deng R, Li D, Huang M, Bi H. 2015. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism. Eur J Pharmacol. 765:131–139. doi: 10.1016/j.ejphar.2015.08.029.
   PubMed Web of Science ®Google Scholar
• Faccioli LAP, Dias ML, Paranhos BA, Dos Santos Goldenberg RC. 2022. Liver cirrhosis: an overview of experimental models in rodents. Life Sci. 301:120615. doi: 10.1016/j.lfs.2022.120615.
   PubMed Web of Science ®Google Scholar
• Friedman SL, Pinzani M. 2022. Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future. Hepatology. 75(2):473–488. doi: 10.1002/hep.32285.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang Y, Li Y, Xia X, Zhao S, Che Y, Sun Y, Lei L. 2016. TGF-beta1 promotes bovine mammary fibroblast proliferation through the ERK 1/2 signalling pathway. Cell Biol Int. 40(7):750–760. doi: 10.1002/cbin.10609.
   PubMed Web of Science ®Google Scholar
• Huang Y, Deng X, Liang J. 2017. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 352(2):420–426. doi: 10.1016/j.yexcr.2017.02.038.
   PubMed Web of Science ®Google Scholar
• Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG. 2017. The ascending pathophysiology of cholestatic liver disease. Hepatology. 65(2):722–738. doi: 10.1002/hep.28965.
   PubMed Web of Science ®Google Scholar
• Jeong HG. 1999. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett. 105(3):215–222. doi: 10.1016/s0378-4274(99)00004-1.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner D. 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 18(3):151–166. doi: 10.1038/s41575-020-00372-7.
   PubMed Web of Science ®Google Scholar
• Kong B, Wang L, Chiang JY, Zhang Y, Klaassen CD, Guo GL. 2012. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 56(3):1034–1043. doi: 10.1002/hep.25740.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hartley DP, Liu J. 1998. Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein. Toxicol Lett. 95(2):77–85. doi: 10.1016/s0378-4274(98)00009-5.
   PubMed Web of Science ®Google Scholar
• Parsons CJ, Takashima M, Rippe RA. 2007. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol. 22 Suppl 1(s1):S79–S84. doi: 10.1111/j.1440-1746.2006.04659.x.
   PubMedGoogle Scholar
• Pollier J, Goossens A. 2012. Oleanolic acid. Phytochemistry. 77:10–15. doi: 10.1016/j.phytochem.2011.12.022.
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Friedman SL. 2017. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 14(7):397–411. doi: 10.1038/nrgastro.2017.38.
   PubMed Web of Science ®Google Scholar
• Tsukada S, Westwick JK, Ikejima K, Sato N, Rippe RA. 2005. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. J Biol Chem. 280(11):10055–10064. doi: 10.1074/jbc.M409381200.
   PubMed Web of Science ®Google Scholar
• Wu H, Chen C, Ziani S, Nelson LJ, Ávila MA, Nevzorova YA, Cubero FJ. 2021. Fibrotic events in the progression of cholestatic liver disease. Cells. 10(5):1107. doi: 10.3390/cells10051107.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang N, Gao R, Zhu Y, Zhang Z, Xu X, Wang J, Li Z, Liu X, Li Z, et al. 2018. TGF-beta1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways. Biochem Biophys Res Commun. 501(4):913–919. doi: 10.1016/j.bbrc.2018.05.081.
   PubMed Web of Science ®Google Scholar
• Yu Z, Sun W, Peng W, Yu R, Li G, Jiang T. 2016. Pharmacokinetics in vitro and in vivo of two novel prodrugs of oleanolic acid in rats and its hepatoprotective effects against liver injury induced by CCl4. Mol Pharm. 13(5):1699–1710. doi: 10.1021/acs.molpharmaceut.6b00129.
   PubMedGoogle Scholar
• Zhang C, Teng Y, Li F, Ho W, Bai X, Xu X, Zhang XQ. 2023. Nanoparticle-mediated RNA therapy attenuates nonalcoholic steatohepatitis and related fibrosis by targeting activated hepatic stellate cells. ACS Nano. 17(15):14852–14870. doi: 10.1021/acsnano.3c03217.
   PubMed Web of Science ®Google Scholar
• Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, Racanelli AC, Zhang L, Ye T, Ding B, et al. 2022. Targeting fibrosis, mechanisms and clinical trials. Sig Transduct Target Ther. 7(1):206. doi: 10.1038/s41392-022-01070-3.
   PubMed Web of Science ®Google Scholar
• Zhao S, Li N, Zhen Y, Ge M, Li Y, Yu B, He H, Shao RG. 2015. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats. Food Chem Toxicol. 86:202–207. doi: 10.1016/j.fct.2015.10.010.
   PubMed Web of Science ®Google Scholar